Delivery Order SPE2DE24D0013-SPE2D626F4614

Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $3,240 by the Defense Logistics Agency's Medical Supply Chain on October 24, 2025, with an ultimate completion date of October 31, 2025. This delivery order, issued under contract number GXTV-10, represents a continuation of the agency's procurement of molecular diagnostic solutions and reagents from Cepheid, the primary federal supplier of advanced diagnostic systems for infectious disease detection. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in federal diagnostics procurement. The place of performance is Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic platform and associated molecular testing capabilities.

This contract award is part of Cepheid's broader federal supply relationship, which includes substantial indefinite delivery contracts with the Department of Veterans Affairs valued at over $39 million through 2030, as well as established procurement relationships with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. Cepheid specializes in providing rapid molecular diagnostic testing for conditions including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and various bacterial infections. The company's federal portfolio demonstrates consistent delivery of diagnostic reagents, test kits, maintenance services, and equipment support across multiple healthcare agencies, supporting both clinical laboratory operations and infectious disease testing requirements throughout the federal healthcare system.